Efficacy of Mycophenolate in Interstitial Lung Disease Associated with Rheumatoid Arthritis
Background: Interstitial lung disease (ILD) is a significant cause of mortality in patients with Rheumatoid Arthritis (RA). Existing studies on the efficacy of Mycophenolate (MPA) for RA-associated ILD are limited, with the largest study including only 26 patients. This study aims to evaluate the ef...
Saved in:
| Main Authors: | Sindhuja Rajendran, Ashish Jacob Mathew, John Mathew, Ruchika Goel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
World Scientific Publishing
2024-01-01
|
| Series: | Journal of Clinical Rheumatology and Immunology |
| Online Access: | https://www.worldscientific.com/doi/10.1142/S2661341724740845 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors associated with interstitial lung disease in patients with rheumatoid arthritis
by: Benyapa Suppa-Udom, et al.
Published: (2024-09-01) -
Animal models of rheumatoid arthritis‐associated interstitial lung disease
by: Li Xiong, et al.
Published: (2021-03-01) -
Rheumatoid Arthritis-Associated Interstitial Lung Disease: Diagnostic Dilemma
by: Mark J. Hamblin, et al.
Published: (2011-01-01) -
Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
by: Juan Chen, et al.
Published: (2013-01-01) -
INTERSTITIAL LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS
by: David Vladimirovich Bestaev, et al.
Published: (2012-12-01)